We describe a case of cardioembolic dominant hemisphere internal carotid artery occlusion in a child with idiopathic dilated cardiomyopathy. The patient was subjected to superselective local intra-arterial thrombolysis using recombinant tissue plasminogen activator (Alteplase; Actilyse®). In presence of good collateral flow local intra-arterial thrombolysis prevented a major dominant hemisphere ischaemic stroke, although post-interventional computed tomographic scans disclosed haemorrhagic conversion in the left corpus striatum. Forty eight months after ischaemic stroke and thrombolysis the patient is ambulatory with a moderate neurologic deficit.
BollaertPEBracardS: Early local intra-arterial thrombolysis for severe middle cerebral artery stroke. Cerebrovasc Dis5: 292–296, 1995.
5.
BoysenGOvergaardK: Thrombolysis in ischaemic stroke: How far from a clinical breakthrough?J Intern Med237: 95–103, 1995.
6.
BricknerME: Cardioembolic stroke. Am J Med100: 465–474, 1996.
7.
BrottTGHaleyEC: Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke23: 632–640, 1992.
8.
BurchMSiddiqiSA: Dilated cardiomyopathy in children: Determinants of outcome. Br Heart J72: 246–250, 1994.
9.
CaroleiAMariniC: A prospective study of cerebral ischemia in the young. Analysis of pathogenic determinants. The National Research Council Study Group. Stroke24: 362–367, 1993.
10.
CastoLCaverniL: Intra-arterial thrombolysis in acute ischemic stroke: Experience with a superselective catheter embedded in the clot. J Neurol Neurosurg Psychiatry60: 667–670, 1996.
11.
del ZoppoGJFerbertA: Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study. Stroke19: 307–313, 1988.
12.
del ZoppoGJHigashidaRT: PROACT: A phase II randomized trial of recombinant pro-urokinase by direct intra-arterial delivery in acute middle cerebral artery stroke. Stroke29: 4–11, 1998.
13.
EzuraMKagawaS: Selective and superselective infusion of urokinase for embolic stroke. Surg Neurol38: 353–358, 1992.
14.
FreyJFGreeneKA: Intrathrombus administration of tissue plasminogen activator in acute cerebrovascular occlusion. Angiology46: 649–656, 1995.
15.
FriedmannRAMoakJPGarsonAJr: Clinical course of idiopathic dilated cardiomyopathy in children. J Am Coll Cardiol18: 152–156, 1991.
16.
GönnerFRemondaI: Local intra-arterial thrombolysis in acute ischemic stroke. Stroke29: 1894–1900, 1998.
17.
GunthardJStockerF: Dilated cardiomyopathy and thrombo-embolism. Eur J Pediatr156: 3–6, 1997.
18.
HackeWKasteM: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA274: 1017–1025, 1995.
19.
HaleyECLevyDE: Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91–180 minutes from onset. Stroke23: 641–645, 1992.
20.
HamiltonMGLeeJS: A comparison of intraarterial and intravenous tissue type plasminogen activator on autologous arterial emboli in the cerebral circulation of rabbits. Stroke25: 651–655, 1994.
21.
HaraTIwamotoM: Dissolution of emboli in rats with experimental cerebral thromboembolism by recombinant human tissue plasminogen activator (TD-2061). Thromb Res59: 703–712, 1990.
22.
HartRG: Cardiogenic embolism to the brain. Lancet339: 589–594, 1992.
23.
KarandeSCKultheSG: Embolic stroke in a child with idiopathic dilated cardiomyopathy. J Postgrad Med42: 84–86, 1996.
24.
KayRWongKS: Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med333: 1588–1593, 1995.
25.
KerrLMAndersonDM: Ischemic stroke in the young: Evaluation and age comparison of patients six months to thirty-nine years. J Child Neurol8: 266–270, 1993.
26.
KoniarisLSGoldhaberSZ: Anticoagulation in dilated cardiomyopathy. J Am Coll Cardiol15: 745–748, 1998.
27.
KummerRHackeW: Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke23: 646–652, 1992.
28.
LasjauniasP: Arterial ischaemic stroke. In: Lasjaunias, Vascular diseases in neonates, infants, and children. Springer Verlag, Wien1997: 393–418.
29.
LaskaMJLanskaDJ: Presentation, clinical course, and outcome of childhood stroke. Pediatr Neurol7: 333–341, 1991.
30.
LewisABChabotM: Outcome of infants and children with dilated cardiomyopathy. Am J Cardiol68: 365–369, 1991.
MoulinTCattinF: Early CT signs in acute middle cerebral artery infarction: Predictive value for subsequent infarct locations and outcome. Neurology47: 366–375, 1996.
34.
OkadaYTamaguchiTMinematsuK: Hemorrhagic transformation in cerebral embolism. Stroke20: 598–603, 1989.
35.
RussellDMaddenKP: Tissue plasminogen activator cerebrovascular thrombolysis in rabbits is dependent on the rate and route of administration. Stroke23: 388–393, 1992.
36.
SandercockPWillemsH: Medical treatment of acute ischaemic stroke. Lancet339: 537–539, 1992.
37.
SilverBWeberJFisherM: Medical therapy for ischemic stroke. Clin Neuropharmacol19: 101–128, 1996.
38.
SpetzlerRFNehlsDG: Cerebral protection against ischemia. In: WoodJH (ed): Cerebral blood flow: Physiologic and clinical aspects. McGraw-Hill, New York1987: 651–676.
39.
The Hemodilution in Stroke Study Group. Hypervolemic hemodilution treatment of acute stroke. Results of a randomized multicenter trial using pentastarch. Stroke20: 317–323, 1989.
40.
The International Stroke Trial Collaborative Group. The International Stroke Trial (IST): A randomized trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet349: 1569–1581, 1997.
41.
The National Institute of Neurologic Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med333: 1581–1587, 1995.
42.
UrbachHRiesF: Local intra-arterial fibrinolyis in thromboembolic “T” occlusions of the internal carotid artery. Neuroradiology39: 105–110, 1997.
43.
WanifuchiHKagawaM: Ischemic stroke in infancy, childhood, and aldolescence. Child's Nerv Syst4: 361–364, 1988.
44.
WijdicksEFNicholsDA: Intra-arterial thrombolysis in acute basilar artery thromboembolism: The initial Mayo Clinic experience. Mayo Clin Proc72: 1005–1013, 1997.
45.
WilesHBMcArthurPD: Prognostic features of children with idiopathic dilated cardiomyopathy. Am J Cardiol15: 1372–1376, 1991.
46.
WilliamsLSGargBP: Subtypes of ischemic stroke in children and young adults. Neurology49: 1541–1545, 1997.
47.
ZeumerHFreitagHJ: Local intra-arterial fibrinolytic therapy in patients with stroke: Urokinase vs. recombinant tissue plasminogen activator (rTPA). Neuroradiology35: 159–162, 1993.
